| SS-Chr 3BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
9 |
|
78.92 |
mmHg |
4.85 |
14.54 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49943 |
461 |
| SS-Chr 3BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
7 |
|
887.86 |
s |
38.76 |
102.54 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50175 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
86.88 |
% |
6.39 |
19.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48811 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
96.28 |
% |
4.53 |
13.6 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48816 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
8 |
|
14.3 |
IU/g |
1.82 |
5.14 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
48880 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
5.33 |
ml/min/g |
0.36 |
1.03 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44773 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
8 |
|
4.33 |
ml/min/g |
0.46 |
1.3 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46262 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
75.14 |
% |
6.28 |
18.85 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48467 |
461 |
| SS-Chr 3BN/Mcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
6 |
|
844.83 |
s |
29.58 |
72.45 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49354 |
461 |
| SS-Chr 3BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49.0 days-63.0 days |
9 |
|
9.24 |
% |
1.05 |
3.16 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49457 |
461 |
| SS-Chr 3BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49.0 days-63.0 days |
9 |
|
11.09 |
% |
2.64 |
7.92 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49758 |
461 |
| SS-Chr 3BN/Mcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
10 |
|
1134.3 |
s |
50.23 |
158.84 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50287 |
461 |
| SS-Chr 3BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
10 |
|
1153.7 |
s |
31.84 |
100.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46609 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
26.21 |
% |
6.91 |
20.74 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48582 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
6 |
|
51.52 |
mmHg |
6.59 |
16.14 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47757 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
6 |
|
77.45 |
mmHg |
8.59 |
21.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44871 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
47.3 |
% |
2.58 |
7.3 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46121 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
52.46 |
% |
3.95 |
11.17 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46126 |
461 |
| SS-Chr 3BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
6 |
|
27.83 |
mmHg |
3.07 |
7.52 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48089 |
461 |
| SS-Chr 3BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
10 |
|
34.9 |
mmHg |
3.33 |
10.55 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48094 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
|
5.29 |
ml/min/g |
0.76 |
2.15 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46257 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
78.73 |
% |
3.86 |
11.58 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48355 |
461 |
| SS-Chr 3BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
8 |
|
231.37 |
beats/min |
14.3 |
40.46 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49001 |
461 |
| SS-Chr 3BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
9 |
|
198.86 |
beats/min |
15.19 |
45.56 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49006 |
461 |
| SS-Chr 3BN/Mcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
10 |
|
932.6 |
s |
36.18 |
114.4 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49359 |
461 |
| SS-Chr 3BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49.0 days-63.0 days |
8 |
|
14.38 |
% |
3.08 |
8.72 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49452 |
461 |
| SS-Chr 3BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49.0 days-63.0 days |
8 |
|
20.92 |
% |
5.35 |
15.12 |
digital scale post excision weight measurement |
|
|
Moms and pups used in studies were fed Teklad |
49753 |
461 |
| SS-Chr 3BN/Mcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
10 |
|
34.5 |
mmHg |
3.14 |
9.92 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50057 |
461 |
| SS-Chr 3BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
10 |
|
894.1 |
s |
37.56 |
118.76 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50180 |
461 |
| SS-Chr 3BN/Mcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
9 |
|
1046.22 |
s |
43.57 |
130.7 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50282 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
9 |
|
56.19 |
mmHg |
4.66 |
13.97 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46472 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
10 |
|
59.04 |
mmHg |
4.3 |
13.58 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46477 |
461 |
| SS-Chr 3BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
7 |
|
1074.86 |
s |
39.42 |
104.31 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46604 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
7 |
|
16.25 |
IU/g |
2.42 |
6.41 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
48874 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
8 |
|
18.62 |
IU/g |
3.31 |
9.36 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45978 |
461 |
| SS-Chr 3BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
15.78 |
IU/g |
1.02 |
3.22 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
45983 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
6 |
|
25.93 |
mmHg |
5.83 |
14.29 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47967 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
|
79.28 |
mmHg |
9.58 |
28.73 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44876 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
103.99 |
% |
11.21 |
27.47 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44974 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
88.25 |
% |
1.92 |
5.44 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48350 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
88.03 |
% |
4.05 |
11.44 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48462 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
10 |
|
30.01 |
mmHg |
4.66 |
14.73 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45330 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
10 |
|
89.04 |
mmHg |
6.57 |
20.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
49948 |
461 |
| SS-Chr 3BN/Mcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
9 |
|
28.0 |
mmHg |
1.77 |
5.32 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
50052 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
32.48 |
% |
4.75 |
14.24 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
48587 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
55.22 |
% |
6.66 |
18.84 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47132 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
48.99 |
% |
3.5 |
11.07 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47137 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
6 |
post-ischemic value/pre-ischemic value x 100% |
36.43 |
% |
6.01 |
14.73 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46375 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
8 |
post-ischemic value/pre-ischemic value x 100% |
33.5 |
% |
6.33 |
17.91 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
46380 |
461 |
| SS-Chr 3BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
8 |
|
228.17 |
beats/min |
8.63 |
24.42 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45203 |
461 |
| SS-Chr 3BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
10 |
|
201.83 |
beats/min |
12.42 |
39.26 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45208 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
9 |
|
22.73 |
mmHg |
5.51 |
16.53 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
45325 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
|
51.46 |
mmHg |
7.5 |
22.5 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47762 |
461 |
| SS-Chr 3BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
|
27.83 |
mmHg |
5.78 |
17.35 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
47972 |
461 |
| SS-Chr 3BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
4.3 |
ml/min/g |
0.16 |
0.5 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44778 |
461 |
| SS-Chr 3BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
84.8 |
% |
8.14 |
24.43 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
Moms and pups used in studies were fed Teklad |
44979 |
461 |